Cite

HARVARD Citation

    Zick, A. et al. (2017). Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients. Medicine. 96 (20), p. . [Online]. 
  
Back to record